Research Article
Detection of β-Lactamases and Outer Membrane Porins among Klebsiella pneumoniae Strains Isolated in Iran
Table 1
Antimicrobial susceptibility testing results of 83 isolates of K. pneumoniae collected from Mofid Children and Taleghani Hospitals, Tehran, Iran.
| | Antibiotic | Resistant number (%) | Intermediate number (%) | Sensitive number (%) |
| | Aztreonam (10 g) | 49 (59%) | 3 (3.6%) | 31 (37.3%) | | Meropenem (10 g) | 20 (24%) | 2 (2.4%) | 61 (73.5%) | | Gentamicin (10 g) | 29 (35%) | 3 (3.6%) | 51 (61.5%) | | Ciprofloxacin (30 g) | 46 (55.5%) | 4 (4.8%) | 33 (39.7%) | | Amikacin (30 g) | 12 (14.4%) | 4 (4.8%) | 67 (80.7%) | | Ceftazidime (30 g) | 46 (55.4%) | 3 (3.6%) | 34 (41%) | | Imipenem (10 g) | 20 (24%) | 2 (2.4%) | 61 (73.5%) | | Cefotaxime (30 g) |
50 (60.2%) | 2 (2.4%) | 31 (37.3%) | | Cefepime (FEP, 30 g) | 30 (36.15%) | 9 (10.8%) | 44 (53.05%) | | Tetracycline (TE, 10 g) | 33 (39.7%) | 3 (3.6%) | 57 (68.6%) | | Ampicillin (AMP, 10 g) | 65 (78.3%) | 2 (2.4%) | 16 (19.2%) | | Piperacillin (PIP, 100 g) | 50 (60.2%) | 0 (0.0%) | 33 (39.7%) | | Ceftriaxone (CRO, 30 g) | 49 (59%) | 2 (2.4%) | 32 (38.5%) | | Cefpodoxime (CPD, 30 g) | 57 (68.6%) | 3 (3.6%) | 23 (27.7%) | | Tigecycline (TGC, 15 g) | 5 (6.02%) | 25 (30.1%) | 53 (63.8%) | | Doripenem (DOR, 10 g) | 20 (24%) | 1 (1.2%) | 62 (74.6%) | | Ertapenem (ETP, 10 g) | 21 (25.3%) | 2 (2.4%) | 57 (68.6%) | | Piperacillin/tazobactam (PTZ, 100/10 g) | 22 (26.5%) | 5 (6.02%) | 56 (67.4%) | | Fosfomycin/trometamol (FOT, 200 g) | 3 (3.6%) | 12 (14.4%) | 68 (82%) |
|
|
